Results 31 to 40 of about 39,317 (170)
Consenso mexicano de cáncer mamario. Cuidados multidisciplinarios en cáncer de mama
Gaceta Mexicana de Oncolog�aEl cáncer mamario impacta en diversas esferas de la vida del paciente y su entorno familiar y social. Se trata de una enfermedad compleja que requiere un abordaje multidisciplinario tanto para el diagnóstico como para el tratamiento, así como en lo relativo al manejo de la toxicidad mediata y tardía del tratamiento sistémico y la radioterapia y también Enrique Soto-Pérez-de-Celis, Dione Aguilar-y-Méndez, Silvia R. Allende-Pérez, Rosa Ma. Álvarez-Gómez, Verónica Cedillo-Compeán, Ma. Teresa de J. Cervantes-Díaz, Mariana Chávez-MacGregor, Mabelid Mabiani-Céspedes, Edith A. Monreal-Carrillo, Ma. Paulina Núñez-Martínez, Guadalupe E. Paredes-Rivera, Edith Rojas-Castillo, Sofía Saba-Cohén, Isabelle A. Timeus-Salvato, Emma L. Verastegui-Avilés, Silvia Vidal-Millán, Talia Wegman-Ostrosky, Claudia Arce-Salinas, Juan E. Bargalló-Rocha, Verónica Bautista-Piña, Guadalupe Cervantes-Sánchez, Christian H. Flores-Balcázar, Ma. del Carmen Lara-Tamburrino, Ana Lluch-Hernández, Antonio Maffuz-Aziz, Víctor M. Pérez-Sánchez, Adela Poitevin-Chacón, Efraín Salas-González, Laura Torrecillas-Torres, Vicente Valero-Castillo, Yolanda Villaseñor-Navarro, Jesús Cárdenas-Sánchez +31 moreopenaire +2 more sourcesConsenso mexicano de cáncer mamario. Manejo del cáncer de mama en poblaciones especiales
Gaceta Mexicana de Oncolog�aEl cáncer mamario en poblaciones especiales (mujeres jóvenes, de edad avanzada, en embarazo o lactancia, hombres) requiere de consideraciones especiales de manejo sistémico, quirúrgico y radioterapia. La décima actualización del Consenso Mexicano Sobre Diagnóstico y Tratamiento del Cáncer Mamario (Colima, enero de 2023) es publicada por sus autores en ...Laura Torrecillas-Torres, Claudia Arce-Salinas, Juan E. Bargalló-Rocha, Verónica Bautista-Piña, Guadalupe Cervantes-Sánchez, Mariana Chávez-MacGregor, Christian H. Flores-Balcázar, Ma. del Carmen Lara-Tamburrino, Ana Lluch-Hernández, Antonio Maffuz-Aziz, Víctor M. Pérez-Sánchez, Adela Poitevin-Chacón, Efraín Salas-González, Enrique Soto-Pérez-de-Celis, Vicente Valero-Castillo, Yolanda Villaseñor-Navarro, Jesús Cárdenas-Sánchez +16 moreopenaire +2 more sourcesRecommended age groups and frequency of mammography screening : a systematic review [PDF]
, 2014 Esta revisão teve por objetivo avaliar a
força de evidência do atual indicador de desempenho
português relativo ao rastreio do Câncer da
Mama através da mamografia, de modo a determinar
o grupo etário e a periodicidade recomendadas.Alves Pereira C, Armstrong K, Braga M, Bárbara Castro, Daniela Pinheiro Ribeiro, Ebell MH, Jaime Correia de Sousa, Joana Oliveira, John Yaphe, Khan K, Magnus MC, Miguel Basto Pereira, Moher D, Nelson HD, Paesmans M +14 morecore +2 more sourcesCancer Health Disparities Among Patients With Early-Stage Estrogen Receptor–Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil
JCO Global OncologyPURPOSEIn 2013, Brazil implemented a federal law (Law 12.732/2012) mandating cancer treatment to begin within 60 days of diagnosis. Among women with newly diagnosed estrogen receptor–positive (ER+) nonmetastatic breast cancer, we describe the diagnosis ...Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende, Fernanda Cesar Moura, Sulene Cunha Sousa Oliveira, Andrea Kazumi Shimada, Renata Arakelian, Anna Luiza Zapalowski Galvão, Bruno Santos Wance de Souza, Amanda Guimarães Castro Custodio, Monalisa Ceciliana Freitas Moreira de Andrade, Yuri Cardoso Rodrigues Beckedorff Bittencourt, Maria Cristina Figueroa Magalhães, Cristiano de Pádua Souza, Carlos Eduardo Paiva, Poliana Albuquerque Signorini, Daniela Jessica Pereira, Angélica Nogueira-Rodrigues, Daniela Dornelles Rosa, Brittany Bychkovsky, Daniele Assad-Suzuki +20 moredoaj +1 more sourceDose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer
npj Breast CancerNeoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best anthracycline-cyclophosphamide (AC) schedule remains to be determined.Renata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, Ana Carolina Marin Comini, Monique Celeste Tavares, Fernanda Madasi, Jose Bines, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Zenaide Silva de Souza, Daniele Assad-Suzuki, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Renata Cangussu, Maria Marcela Fernandes Monteiro, Paulo M. Hoff, Laura Testa, Romualdo Barroso-Sousa +22 moredoaj +1 more sourceCancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study
BreastBackground: In pivotal CDK4/6 inhibitor (CDK4/6i) adjuvant trials, most patients received chemotherapy (CT). However, the role of CDK4/6i in patients spared CT by a genomic signature remains unclear.Leandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, Daniele Assad-Suzuki, Daniel Argolo, Solange Moraes Sanches, Laura Testa, José Bines, Rafael Aliosha Kaliks, Debora de Melo Gagliato, Romualdo Barroso-Sousa, Tatiana Strava Corrêa, Andrea Kazumi Shimada, Carlos Henrique dos Anjos, Rudinei Linck, Thais Baccili Cury Megid, Daniel Negrini Batista, Daniel Musse Gomes, Marcelle Goldner Cesca, Débora Gaudêncio, Larissa Matos Almeida Moura, Julio Antonio Pereira de Araújo, Renata Colombo Bonadio, Zenaide Silva de Souza, Juliana Rodrigues Beal, Mario Machado Lopes, Leticia Telles Sales, Júlia Leal Franco Parisi Marlière, Max Senna Mano +28 moredoaj +1 more sourceRemoving the blindfolds: knowledge of blind women about breast cancer
Revista de Pesquisa Cuidado é Fundamental Online, 2015 Objetivo: Compreender o conhecimento de mulheres cegas sobre fatores de risco e detecção precoce do câncer de mama. Método:Estudo transversal, desenvolvido em 2010, no Instituto dos Cegos, Campina Grande/PB, Brasil.Participaram 16 mulheres que ...Giovanna Karinny Pereira Cruz, Inacia Sátiro Xavier de França, Cibely Freire de Oliveira, Francisco Stélio de Sousa, Alexsandro Silva Coura +4 moredoaj +7 more sourcesEmployment Status Among Brazilian Women With Estrogen Receptor‐Positive Nonmetastatic Breast Cancer
Cancer MedicineBackground Employment is a critical determinant of quality of life, social reintegration, and financial stability for breast cancer survivors. International studies have shown that return‐to‐work (RTW) rates vary widely, ranging from 27% to over 80 ...Daniele Assad‐Suzuki, Luciana Castro Garcia Landeiro, Danielle Laperche‐Santos, Heloisa Resende, Fernanda Cesar Moura, Sulene Cunha Sousa Oliveira, Andrea Kazumi Shimada, Renata Arakelian, Anna Luiza Zapalowski Galvão, Bruno Santos Wance deSouza, Amanda Guimarães Castro Custódio, Monalisa Ceciliana Freitas Moreira deAndrade, Yuri Cardoso Rodrigues Beckedorff Bittencourt, Maria Cristina Figueroa Magalhães, Cristiano de Pádua Souza, Carlos Eduardo Paiva, Poliana Albuquerque Signorini, Ariane Vieira Carvalho, Daniela Jessica Pereira, Laura Cereser Albaneze, Angélica Nogueira‐Rodrigues, Daniela Dornelles Rosa, Romualdo Barroso‐Sousa +22 moredoaj +1 more source